LLY

999.53

-0.35%↓

JNJ

243.27

-0.25%↓

ABBV

226.59

-0.6%↓

NVS

161.17

-0.97%↓

AZN

195.34

+0.06%↑

LLY

999.53

-0.35%↓

JNJ

243.27

-0.25%↓

ABBV

226.59

-0.6%↓

NVS

161.17

-0.97%↓

AZN

195.34

+0.06%↑

LLY

999.53

-0.35%↓

JNJ

243.27

-0.25%↓

ABBV

226.59

-0.6%↓

NVS

161.17

-0.97%↓

AZN

195.34

+0.06%↑

LLY

999.53

-0.35%↓

JNJ

243.27

-0.25%↓

ABBV

226.59

-0.6%↓

NVS

161.17

-0.97%↓

AZN

195.34

+0.06%↑

LLY

999.53

-0.35%↓

JNJ

243.27

-0.25%↓

ABBV

226.59

-0.6%↓

NVS

161.17

-0.97%↓

AZN

195.34

+0.06%↑

Kodu・Aktsiate loetelu・Arcutis Biotherapeutics Inc

Arcutis Biotherapeutics Inc

Avatud

SektorTervishoid

24.55 -0.81

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

24.28

Max

25.29

Põhinäitajad
By Trading Economics
Sissetulek	10M 17M
Müük	30M 130M
Aktsiakasum	0.13
Kasumimarginaal	13.432
Töötajad	354
EBITDA	11M 22M

Soovitused
By TipRanks
Soovitused	Tugev "osta" hinnang
12 kuu keskmine prognoos	+43.04% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	5. mai 2026

Turustatistika
By TradingEconomics
Turukapital	-190M 3B
Eelmine avamishind	25.36
Eelmine sulgemishind	24.55

Uudiste sentiment

By Acuity

35%

65%

92 / 351 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Strong Bearish Evidence

12.42 / 14.93 Toetus ja vastupanu

Arcutis Biotherapeutics Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

9. märts 2026, 18:13 UTC

Omandamised, ülevõtmised, äriostud

Shell to Sell Jiffy Lube to Monomoy in $1.3 Billion Deal -- Update

9. märts 2026, 17:20 UTC

Uudisväärsed sündmused

U.S. Ag Industry Calls for Government Intervention on Fertilizer Prices

9. märts 2026, 17:15 UTC

Omandamised, ülevõtmised, äriostud

Shell to Sell Jiffy Lube and Premium Velocity to Monomoy for $1.3 Billion

10. märts 2026, 00:00 UTC

Uudisväärsed sündmused

Why Iranian Regime Change Would Transform Global Energy Markets -- WSJ

9. märts 2026, 23:52 UTC

Market Talk

Gold Steady; May Be Supported by Dollar's Weakness -- Market Talk

9. märts 2026, 23:50 UTC

Market Talk

Nikkei May Rise as Fears About Higher Energy Prices Ease -- Market Talk

9. märts 2026, 23:50 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

9. märts 2026, 23:46 UTC

Market Talk

Uudisväärsed sündmused

Correction to Crude Prices Market Talk on March 9

9. märts 2026, 23:42 UTC

Market Talk

Uudisväärsed sündmused

Oil Futures Fall Amid Developments That Could Help Supply -- Market Talk

9. märts 2026, 23:08 UTC

Uudisväärsed sündmused

Front-Month WTI Futures Drop 7.9% to $87.29/bbl, ICE Data Show

9. märts 2026, 23:07 UTC

Uudisväärsed sündmused

Front-Month WTI Futures Fall After Trump Says Iran War Will Be Over 'Very Soon'

9. märts 2026, 21:29 UTC

Omandamised, ülevõtmised, äriostud

Fortescue Now Fully Owns Peru's Canariaco Copper Project

9. märts 2026, 21:28 UTC

Omandamised, ülevõtmised, äriostud

Fortescue Completes Acquisition of Remaining Alta Copper Shares

9. märts 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

9. märts 2026, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

9. märts 2026, 20:47 UTC

Uudisväärsed sündmused

The 24 Hours When Oil Markets Went Wild -- WSJ

9. märts 2026, 20:33 UTC

Uudisväärsed sündmused

Stock Market Today: Oil Slips, Stocks Bounce on Trump War-Progress Comments Headline -- WSJ

9. märts 2026, 20:14 UTC

Market Talk

Uudisväärsed sündmused

Oil Moves Lower As Trump Says War Could End Soon -- Market Talk

9. märts 2026, 19:33 UTC

Uudisväärsed sündmused

High Oil Prices Could Crimp Convenience Store Margins -- Barrons.com

9. märts 2026, 19:17 UTC

Market Talk

Uudisväärsed sündmused

Prospect of Added Supply From Oil Reserves Ease Inflation Fears -- Market Talk

9. märts 2026, 19:14 UTC

Market Talk

Oil Settles Off Highs As G7 Discusses Tapping Reserves -- Market Talk

9. märts 2026, 19:00 UTC

Market Talk

U.S. Natural Gas Futures Settle Lower -- Market Talk

9. märts 2026, 18:23 UTC

Market Talk

Uudisväärsed sündmused

BofA Drops Canada Rate-Cut Call on Higher Oil Prices -- Market Talk

9. märts 2026, 17:58 UTC

Omandamised, ülevõtmised, äriostud

Shell to Sell Jiffy Lube to Monomoy in $1.3B Deal -- Update

9. märts 2026, 17:57 UTC

Omandamised, ülevõtmised, äriostud

Activist Investors Target Food Companies as Growth Slows. Lamb Weston Is the Latest. -- Barrons.com

9. märts 2026, 17:41 UTC

Uudisväärsed sündmused

U.S. and Western Allies Turn to Reserves to Counteract Gulf Oil Crisis -- WSJ

9. märts 2026, 17:41 UTC

Market Talk

Uudisväärsed sündmused

Reports of Saudi Production Shut-Ins Keep Bid in Crude -- Market Talk

9. märts 2026, 17:08 UTC

Market Talk

Canada Rate Outlook Shifts From Long Pause to Late 2026 Hike -- Market Talk

9. märts 2026, 17:04 UTC

Market Talk

Uudisväärsed sündmused

Global Forex and Fixed Income Roundup: Market Talk

9. märts 2026, 17:04 UTC

Market Talk

Uudisväärsed sündmused

Treasury Yields, Dollar Off Highs as G7 Tackles Oil Shock -- Market Talk

Võrdlus sarnastega

Hinnamuutus

Arcutis Biotherapeutics Inc Prognoos

Hinnasiht

By TipRanks

43.04% tõus

12 kuu keskmine prognoos

Keskmine 34.33 USD 43.04%

Kõrge 36 USD

Madal 31 USD

Põhineb 9 Wall Streeti analüütiku instrumendi Arcutis Biotherapeutics Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

9 ratings

Osta

Hoia

Müü

Põhineb 9 analüütiku instrumendi Arcutis Biotherapeutics Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

12.42 / 14.93Toetus ja vastupanu

Recent bearish events outweigh bullish events.

There is one bullish event.

Sentiment

By Acuity

92 / 351 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Arcutis Biotherapeutics Inc

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical ZORYVE for the treatment of scalp and body psoriasis and seborrheic dermatitis; ARQ-252, a selective topical janus kinase type 1 inhibitor for hand eczema and vitiligo; ARQ-255, a topical JAK1 inhibitor for alopecia areata; and ARQ-234, a CD200R fusion protein for the treatment of moderate-to-severe atopic dermatitis. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.